Daaweynta kansarka sanbabada ee dhexe oo loo adeegsado mindi xawaare leh

La qaybso Post this

Daaweynta kansarka sanbabada ee unugyada yar

Daawaynta kansarka sanbabada inta badan waxay isticmaashaa qaliin, radiotherapy iyo chemotherapy, iyo qaliinka ayaa weli ah habka ugu waxtarka badan ee lagu daweyn karo kansarka sanbabada marxaladaha hore iyo dhexe. Si kastaba ha noqotee, kansarka sanbabada dhexe, sababtoo ah meesha gaarka ah ee nabarka, hababka qalliinka ee dhaqameed way adag tahay in la fuliyo, bukaannadu waxay inta badan lumiyaan fursadda daaweynta.

Central lung cancer refers to lung cancer that occurs in the bronchi, lobular bronchus, and lung bronchus, with squamous carcinoma and undifferentiated carcinoma mostly. Surgery is rarely used for central kansarka sanbabada. This is because central lung cancer is located near the hilum. It is difficult to remove, and the surgical effect is not ideal. It is easy to induce bone metastasis . Therefore, in the past, clinicians often were helpless when treating central lung cancer.

Xitaa iyada oo la hagaajinayo tiknoolajiyada qalliinka sambabada, isticmaalka pneumonectomy intrapericardial pneumonectomy ayaa ballaarisay calaamadaha qalliinka ilaa xad waxayna kordhisay heerka dib-u-soo-celinta. Si kastaba ha noqotee, marka loo eego xogta bukaan-socodka, daaweynta kansarka sambabada dhexe, waxtarka qalliinka qalliinka si fiican looma qiimeeyo, gaar ahaan bukaannada qaba kansarka sambabada sare, qalliinka qalliinka guud ahaan waa la niyad-jabiyaa. Daaweynta kansarka sanbabada dhexe, xitaa haddii ay tahay thoracotomy, badanaa waa qalliin sahaminta iyo qalliinka palliative. Bukaannada da'da weyn ayaa wadnahoodu xun yahay wayna adagtahay in la dhaafo suuxdinta qalliinka.

The birth of EDGE has completely changed the dilemma of the treatment of central lung cancer. This technology can effectively remove buro lesions in vitro and remove the central lung cancer lesions in vitro. The treatment effect can be comparable to surgical operations, but there is no surgical operation for patients. Caused by trauma and side effects.

Experts from the Global Oncologist Network introduced that EDGE, which was launched in 2014, is by far the most advanced in-vitro non-invasive tumor removal technology. It can remove tumor lesions in the body without any damage to the patient’s body and immune system. This technique is particularly suitable for patients with tumors that were previously inoperable, such as lung cancer, brain tumors, spine tumors, madaxa iyo luqunta tumors, pancreatic cancer, prostate cancer and other diseases.

Male, 53 years old, suffering from kansarka sanbabada ee aan yareyn with multiple metastatic brain tumors. In early June 2014, he went to Henry Ford Hospital for EDGE non-invasive radiosurgery. EDGE treatment 3 times, continuous daily treatment, once a day, each time takes about 12 minutes. The first time after operation, the patient’s headache was obviously relieved, and the patient is generally in good condition so far. During the follow-up in early September, the local hospital in Taipei underwent MRI examination: 0.9 and 4 cm3 burooyinka maskaxda almost disappeared, and 6.5 cm3 tumors in the lungs decreased by more than 98%.

Nidaamka EDGE Radiosurgery (Nidaamka daaweynta burooyinka shucaaca ee EDGE) waxaa soo saartay shirkad Maraykan ah oo Varian ah waxaana ansixiyay FDA US Janaayo 23, 2013. EDGE ilaa hadda waa tignoolajiyada ka saarista burooyinka ee ugu waxtarka badan. Waxay u isticmaashaa GPS-ka u gaarka ah ee FDA's Calypso® ee nidaamka Jidhka iyo nidaamka la socodka iftiinka dusha sare ee la ansixiyay Julaay 21, 2014 si ay si firfircooni leh ula socdaan oo ay u quful waqtiga dhabta ah ee soo noqnoqda sare ee ilaa 10 millise seconds. Inta lagu jiro daawaynta, buro "ka baxsatey", oo ay weheliso jiil cusub oo IGRT ah iyo tignoolajiyada kale ee hagida sawirka, waxayna isticmaashaa xoog sare oo HD-MLC ah oo gaar ah ilaa 2400MU / min si ay meesha uga saarto nudaha burooyinka iyada oo aan ku dhawaad ​​sax ahayn hadhaaga.

Nidaamkii EDGE ee ugu horreeyay adduunka wuxuu degay Mareykanka Nidaamka Caafimaadka Henry Ford (HFHS, American Henry Ford Medical Group) Sebtembar 2013, wuxuuna bilaabay qalliinkiisii ​​​​ugu horreeyay Maarso 2014. 

EDGE has an excellent therapeutic effect on solid tumors such as head tumors, lung cancer including breast cancer, spine tumors, kansarka beerka and other tumors that are difficult to perform in conventional surgery. The entire treatment process is non-invasive, no anesthesia, no hospitalization, each treatment time is 8-20 minutes, once a day, up to 5 times, continuous daily treatment. EDGE treatment has almost no side effects, almost no damage to important organs, and almost no effect on the body’s anti-cancer immune system.

Faa'iidooyinka qaliinka shucaaca ee EDGE

Ø Waqtiga daawaynta gaaban: 8-20 daqiiqo mar kasta;

Ø Waqtiyada daaweynta: wadar ahaan 1-5 jeer, daaweyn joogto ah, hal mar maalintii;

Ø Waxtarka sare: burooyin badan ayaa isku mar la nadiifin karaa;

Ø La socodka waqtiga dhabta ah ee baxsashada iyo ka saarida burada: Raad raac oo quful buro “ka baxso” oo leh inta jeer ee aad u sareysa ee 10 millise seconds kana saar;

Ø Saamaynta wanaagsan ee saarista: xoogga sare, saxnaanta sare iyo saxnaanta sare, ka saarida dhamaystiran ee nudaha burada oo aan ku dhawaad ​​​​wax hadhaaga ah;

Ø Ku dhawaad ​​ma jiraan wax dhaawac ah oo soo gaadhay xubnaha muhiimka ah: ku dhawaad ​​waxyeello ma gaadho unugyada iyo xubnaha muhiimka ah;

Ø Waxyeelada difaaca jidhka ee ka hortagga kansarka waxay leedahay saamayn yar: ku dhawaad ​​wax saamayn ah kuma laha habdhiska difaaca ee bukaanka;

Ø Fududeynta: suuxin iyo isbitaal la'aan;

Ø Waxyeellooyinka soo raaca: Ku dhawaad ​​ma jiraan waxyeellooyin.

Ku soo Dhawo Wargeyskayaga

Hel wax cusub oo waligaa ha ka maqnaan blog ka Cancerfax

Inbadan Oo La Baadho

Daawaynta Unug ee CAR T ee Ku Salaysan Aadanaha: Horumarrada iyo Caqabadaha
Daaweynta T-Cell-ka Baabuurka

Daawaynta Unug ee CAR T ee Ku Salaysan Aadanaha: Horumarrada iyo Caqabadaha

Daawaynta Unugyada CAR-ku-salaysan ee bini-aadmigu waxa ay wax ka beddeshaa daawaynta kansarka iyada oo hidde ahaan wax ka beddeleysa unugyada difaaca bukaanka si ay u beegsato oo ay u burburiso unugyada kansarka. Ka faa'iidaysiga awoodda habka difaaca jidhka, daawayntani waxay bixiyaan daweyn awood leh oo shakhsi ahaaneed oo leh suurtagalnimada cafis waara ee noocyada kala duwan ee kansarka.

Fahamka Cytokine Release Syndrome: Sababaha, Calaamadaha, iyo Daaweynta
Daaweynta T-Cell-ka Baabuurka

Fahamka Cytokine Release Syndrome: Sababaha, Calaamadaha, iyo Daaweynta

Cytokine Release Syndrome (CRS) waa falcelin habdhiska difaaca oo inta badan ka dhasha daawaynta qaarkood sida immunotherapy ama daawaynta unugga CAR-T. Waxay ku lug leedahay sii-deynta xad-dhaafka ah ee cytokines, taasoo keenta calaamado u dhexeeya qandho iyo daal ilaa dhibaatooyin nafta halis gelin kara sida dhaawaca xubnaha. Maareyntu waxay u baahan tahay kormeer taxadar leh iyo xeelado faragelineed.

Ma u baahan tahay caawimaad? Kooxdayadu waxay diyaar u yihiin inay ku caawiyaan.

Waxaan u rajeynaynaa caafimaad deg-deg ah mid aad jeceshahay iyo mid kuu dhow.

Bilow sheekada
Waxaan nahay Online! Nala hadal!
Sawir koodka
Hello,

Ku soo dhawoow CancerFax!

CancerFax waa madal horudhac ah oo u heellan in lagu xidho shakhsiyaadka wajahaya kansarka heerka sare ee daawaynta unugyada sida CAR T-Cell therapy, daawaynta TIL, iyo tijaabooyinka caafimaad ee adduunka oo dhan.

Nala soo socodsii waxaan kuu qaban karno.

1) Daaweynta kansarka ee dibadda?
2) CAR T-Cell therapy
3) Tallaalka kansarka
4) La-talinta fiidiyowga ee khadka tooska ah
5) daawaynta Proton